| Product Code: ETC7645308 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Atopic Dermatitis Clinical Trials Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Atopic Dermatitis Clinical Trials Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Atopic Dermatitis Clinical Trials Market - Industry Life Cycle |
3.4 Israel Atopic Dermatitis Clinical Trials Market - Porter's Five Forces |
3.5 Israel Atopic Dermatitis Clinical Trials Market Revenues & Volume Share, By Molecule Type, 2021 & 2031F |
3.6 Israel Atopic Dermatitis Clinical Trials Market Revenues & Volume Share, By Study Designs, 2021 & 2031F |
3.7 Israel Atopic Dermatitis Clinical Trials Market Revenues & Volume Share, By Phase, 2021 & 2031F |
4 Israel Atopic Dermatitis Clinical Trials Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of atopic dermatitis in Israel |
4.2.2 Increasing investments in research and development for dermatology treatments |
4.2.3 Favorable regulatory environment for conducting clinical trials in Israel |
4.3 Market Restraints |
4.3.1 High competition among pharmaceutical companies in the atopic dermatitis market |
4.3.2 Stringent regulatory requirements for clinical trial approvals |
4.3.3 Limited availability of experienced dermatologists for conducting clinical trials |
5 Israel Atopic Dermatitis Clinical Trials Market Trends |
6 Israel Atopic Dermatitis Clinical Trials Market, By Types |
6.1 Israel Atopic Dermatitis Clinical Trials Market, By Molecule Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Atopic Dermatitis Clinical Trials Market Revenues & Volume, By Molecule Type, 2021- 2031F |
6.1.3 Israel Atopic Dermatitis Clinical Trials Market Revenues & Volume, By Small molecules, 2021- 2031F |
6.1.4 Israel Atopic Dermatitis Clinical Trials Market Revenues & Volume, By Large Molecules, 2021- 2031F |
6.2 Israel Atopic Dermatitis Clinical Trials Market, By Study Designs |
6.2.1 Overview and Analysis |
6.2.2 Israel Atopic Dermatitis Clinical Trials Market Revenues & Volume, By Interventional, 2021- 2031F |
6.2.3 Israel Atopic Dermatitis Clinical Trials Market Revenues & Volume, By Observational, 2021- 2031F |
6.3 Israel Atopic Dermatitis Clinical Trials Market, By Phase |
6.3.1 Overview and Analysis |
6.3.2 Israel Atopic Dermatitis Clinical Trials Market Revenues & Volume, By Phase I, 2021- 2031F |
6.3.3 Israel Atopic Dermatitis Clinical Trials Market Revenues & Volume, By Phase II, 2021- 2031F |
6.3.4 Israel Atopic Dermatitis Clinical Trials Market Revenues & Volume, By Phase III, 2021- 2031F |
6.3.5 Israel Atopic Dermatitis Clinical Trials Market Revenues & Volume, By Phase IV, 2021- 2031F |
7 Israel Atopic Dermatitis Clinical Trials Market Import-Export Trade Statistics |
7.1 Israel Atopic Dermatitis Clinical Trials Market Export to Major Countries |
7.2 Israel Atopic Dermatitis Clinical Trials Market Imports from Major Countries |
8 Israel Atopic Dermatitis Clinical Trials Market Key Performance Indicators |
8.1 Number of atopic dermatitis clinical trials initiated in Israel |
8.2 Patient enrollment rates in atopic dermatitis clinical trials |
8.3 Success rate of atopic dermatitis clinical trials in meeting efficacy endpoints |
9 Israel Atopic Dermatitis Clinical Trials Market - Opportunity Assessment |
9.1 Israel Atopic Dermatitis Clinical Trials Market Opportunity Assessment, By Molecule Type, 2021 & 2031F |
9.2 Israel Atopic Dermatitis Clinical Trials Market Opportunity Assessment, By Study Designs, 2021 & 2031F |
9.3 Israel Atopic Dermatitis Clinical Trials Market Opportunity Assessment, By Phase, 2021 & 2031F |
10 Israel Atopic Dermatitis Clinical Trials Market - Competitive Landscape |
10.1 Israel Atopic Dermatitis Clinical Trials Market Revenue Share, By Companies, 2024 |
10.2 Israel Atopic Dermatitis Clinical Trials Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here